Article
BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors.
Pigment cell & melanoma research - 1 Nov 2018
Doxie Deon B, Greenplate Allison R, Gandelman Jocelyn S, Diggins Kirsten E, Roe Caroline E, Dahlman Kimberly B, Sosman Jeffrey A, Kelley Mark C, Irish Jonathan M
Abstract excerpt
Little is known about the in vivo impacts of targeted therapy on melanoma cell abundance and protein expression. Here, 21 antibodies were added to an established melanoma mass cytometry panel to measure 32 cellular features, distinguish malignant cells, and characterize dabrafenib and trametinib responses in BRAFV600mut melanoma. Tumor cells were biopsied before neoadjuvant therapy and compared to cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
